2017-10-21

[#DIV28SUPER] Opportunity for Doctoral Studies in Health Behavior with Research Focus on Addictions

Dear Colleagues and Students,

 

Faculty in the Department of Health Education and Behavior at the University of Florida (UF) are seeking doctoral students for their Ph.D. program in Health and Human Performance with Concentration in Health Behavior. The program is well suited to outstanding students who seek intensive research training and education pertaining to health psychology, public health and community-based research for whom clinical training is not a primary or immediate interest. Admission to the doctoral program comes with a graduate assistantship that provides a tuition waiver covering full-time coursework, health insurance, plus stipend.

 

The topic of addictions is a research strength throughout UF with international leaders in this area located throughout the university. Several faculty in the Department have research programs focused on the addictions, including Drs. Jalie Tucker, JeeWon Cheong, Robert Leeman, Richard Yi, Ali Yurasek and beginning in Spring 2018, Megan McVay. In particular, Drs. Leeman and Yurasek are actively seeking new doctoral students for Fall 2018.

 

Dr. Leeman’s research focus is on relationships between addictive behaviors and other difficulties with self-control. He and his collaborators contribute to understanding the etiology of addictions and in testing new interventions to ameliorate addictive behaviors. His research pertains primarily to the adolescent and young adult populations. Dr. Leeman’s group is currently conducting two NIH-funded studies to test mobile interventions to reduce alcohol use and related risky sexual behavior.

 

Dr. Yurasek’s primary research interests include using behavioral economic theory to identify risk factors for substance misuse and poor response to treatment as well as examining marijuana use amid the changing legal climate.

 

Interested students should contact Dr. Yurasek (a.yurasek@ufl.edu) or Dr. Leeman (robert.leeman@ufl.edu) directly to learn more about research and mentorship opportunities with their respective research groups. Students can learn more about the doctoral program on the web at  http://hhp.ufl.edu/about/academics/phd/heb-phd/ or by contacting Academic Advisor Ms. Jenny Neelands by email at jennifer4@ufl.edu or by phone at 352-294-1803 or Dr. Virginia Dodd, Associate Professor and Acting Graduate Coordinator by email at vdodd@dental.ufl.edu.  Review of applications will begin on November 1st but submission after that date is possible.

 

Thank you for your consideration.

 

 

 

Robert F. Leeman, Ph.D.
Associate Professor

Department of Health Education and Behavior

University of Florida

Florida Gymnasium, Room 14

PO Box 118210
Gainesville, FL  32611

Phone: (352) 294-1808

Fax: (352) 392-1909

Email: robert.leeman@ufl.edu

http://heb.hhp.ufl.edu/index.php/about-2/department-directory/leeman-robert/

 

2017-10-19

[#DIV28SUPER] NIDA Neuroscience Update, October 19, 2017

Table of Contents

I.                  Meet NIDA Staff at the Annual Meeting for Society For Neuroscience, Nov 10-16, 2017

II.               Exploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33) (RFA-DA-18-016)  Application Receipt Date:  December 13, 2017 by 5 pm local time of applicant organization.

III.              Request for Information (RFI): Seeking Input from Surgeons and Interventionalists on Improving the Clinical Study and Use of New and Established Peripheral Neuromodulation Devices  NOT-RM-17-023

IV.              Request for Information: Trans-NIH Strategic Plan for Research on Women’s Health

I.  Come meet NIDA Staff at the Annual Meeting Society for Neuroscience, Nov 10-16, 2017.  NIDA staff will be at the NIDA-NIAAA Mini-Convention, Friday Nov 10, 2017 Walter E. Washington Convention Center, Rm 207A, Washington, DC and at the NIDA Booth. To make an appointment with NIDA Staff to discuss a proposal or funding opportunities see email addresses below. 

Division of Neuroscience and Behavior

Office of the Director

email

telephone

Rita Valentino, Ph.D. Director

valentinorj@nida.nih.gov

301-827-5436

Roger Little, Ph.D. Deputy Director

alittle@nida.nih.gov

301-435-1316

Steven Grant, Ph.D. Coordinator for Translation, Cognitive Neuroscience, Neuroimaging

sgrant@nida.nih.gov

301-443-8869

Training

Beth Babecki, M.A., Lead coordinator: Training Hub, Basic F30, F31, F32, T32

bbabecki@mail.nih.gov

301-435-0899

Mary Kautz, Ph.D. Program Director: Clinical, T32

kautzm@nida.nih.gov

301-443-3206

Roger Sorenson, Ph.D., M.P.A., Program Director:  Basic K99/R00

rsorense@nida.nih.gov

301-443-3205

Yu (Woody) Lin, Ph.D., M.D. Program Director: Clinical K99/R00

ylin1@nida.nih.gov

301-435-1318

Behavioral and Cognitive Neuroscience Branch

Mary Kautz, Ph.D., Acting Chief,  TRSP Liason Behavioral Pharmacology, Nicotine

kautzm@nida.nih.gov

301-443-3206

Cora Lee Wetherington, Ph.D. Program Director: Women and Sex/Gender Differences- Research Coordinator; Sex/Gender Differences, Vulnerability, Development

cwetheri@nida.nih.gov

301-435-1319

Zu-In (Shelly) Su, Ph.D. Program Director: Cognition, Affect, Operant Behavior

shelley.su@nih.gov

301-402-3869

Integrative Neuroscience Branch

Roger Sorensen, Ph.D. , M.P.A., Chief, Molecular and Cellular Neurobiology, Neural Circuits, Glia

rsorense@nida.nih.gov

301-443-3205

Olivier Berton, Ph.D. Program Director: Cells, Circuits & Neuroplasticity in Motivation and Addiction

olivier.berton@nih.gov

301-827-7771

Vani Pariyadath, Ph.D., Program Director: Cognitive Neuroscience, Neuroimaging of addiction-related circuitry

pariyadathv@nida.nih.gov

301-443-3209

Vishnudutt Purohitt, D.V.M., Ph.D., Program Director: HIV, Inflammation and Immune System, Pain

vpurohit@nida.nih.gov

301-594-5753

Yu (Woody) Lin, Ph.D., Porgram Director: Cognitive Neuroscience, Neuro Aids, Pain, CNS Plasticity, Neuromodulation

ylin1@nida.nih.gov

301-435-1318

Chemistry, Pharmacology, and Physiological Systems Branch

Rao Rapaka, Ph.D. Chief, Medicinal Chemistry, Nanotechnology, ADME(PK//PD) and Systems Biology (proteomics, metabolomics, tyrptomics, Lipidomics, etc)

rrapaka@mail.nih.gov

301-435-1304

Kristopher Bough, Ph.D., Program Director and SBIR/STTR Division Coordinator: Basic Drug Discovery Program

boughk@nida.nih.gov

301-443-9800

Paul Hillery, Ph.D., Program Director: Organic and Medicinal Chemistry, Structural Biology

phillery@mail.nih.gov

301-435-1306

Genetics, Epigenetics, and Developmental Neuroscience Branch

Jonathan D. Pollock, Ph.D., Chief, Molecular Neuroanatomy, Genetics of Addiction, Molecular Basis of Memory, Molecular Genetics or Host Response

jpollock@mail.nih.gov

301-435-1309

Amy Lossie, Ph.D., Program Director: Bioinformatics, Statistical Genetics, Transposable Elements, Splicing, RNA binding Proteins.

amy.lossie@nih.gov

301-435-1308

John Satterlee, Program Director: Epigenetics, Non-coding RNAs, Model Organism Genetics, Functional Genomics, Signal Transduction

satterleej@mail.nih.gov

301-435-1020

Da-Yu Wu, Program Director: Neural Development, Gene Regulation

wudy@mail.nih.gov

301-435-4649

 

II. Exploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33)
(RFA-DA-18-016)  Application Receipt Date:  December 13, 2017 by 5 pm local time of applicant organization.

  • Purpose:  This initiative will support exploratory projects that exploit HIV or host genomic or nucleomic information to understand HIV latency in individuals with substance use disorders (SUDs).

 

  • NIDA intends to commit $2 million dollars in FY2018 to fund 3-4 awards

 

  • Application budgets are limited to $650,000 direct costs and must reflect the actual needs of the proposed project.

 

  • The R61/R33 grant mechanism includes an exploratory high risk/high pay off R61 phase (three years).  Near the end of the R61 phase, NIDA scientific staff will review progress made towards the proposed R61 milestones and recommend a subset of R61 projects for continued support through the R33 phase (two years) pending merit and the availability of funds

 

  • Nucleomics:  robust nuclear architecture assays (e.g. Hi-C, ChIA-PET, DamID, cellular imaging approaches) 

 

 

III. Request for Information (RFI): Seeking Input from Surgeons and Interventionalists on Improving the Clinical Study and Use of New and Established Peripheral Neuromodulation Devices  NOT-RM-17-023: The NIH SPARC (Stimulating Peripheral Activity to Relieve Conditions) program aims to enable the development of the next generation of neuromodulation devices informed by promoting the systematic development of high resolution neural circuit maps within organs and tissues of the peripheral nervous system. Therapeutic development may be stimulated by increasing the understanding of human peripheral neuroanatomy and its relationship to organ function, which may be facilitated by stronger linkages between clinical practice and basic research. To guide future efforts, SPARC is requesting input from surgeons, interventionalists, and other relevant clinicians on partnering to improve the clinical study of neuromodulation devices, specifically in applications involving peripheral or spinal neuromodulation of organ function. Comments should be provided by 1 December 2017.

 

IV.Request for Information: Trans-NIH Strategic Plan for Research on Women’s Health

The NIH Office of Research on Women’s Health has published a Request for Information (RFI) on the next Trans-NIH Strategic Plan for Research on Women’s Health.  It can be found in the NIH Guide (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-108.html).  A link within the RFI will take you to a form where you can submit your ideas.  Feedback is sought on 3 cross-cutting themes and goals under consideration:  (1) Expand the Exploration of Sex as a Biological Variable (SABV) in NIH Research, (2) A Multi-Dimensional Approach to the Science of Women's Health, and  (3) Quality of Life and Disease Burden over the Life-Course.  Your feedback is requested by November 10.

 

 The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309

 

[#DIV28SUPER] Position Announcement

Psychology Training in Alcohol Research Fellowship
(T‐32 Training Grant)
University of Washington
Department of Psychiatry & Behavioral Sciences
Department of Psychology, Addictive Behaviors Research Center

This is a two‐year appointment, commencing no earlier than July 1st and no later than December 31st
of each year, within the Department of Psychiatry & Behavioral Sciences and the Addictive Behaviors
Research Center in the Department of Psychology, and is funded by the National Institute on Alcohol
Abuse and Alcoholism (Principal Investigator, Dr. Mary Larimer). This fellowship will provide
training for individuals who wish to pursue a career in alcohol research, with an emphasis on the
etiology and prevention of problem drinking and alcohol dependence.
As this topic will be approached from both psychosocial and bio‐behavioral perspectives,
individuals with background training in relevant areas of psychology (clinical, health psychology,
behavioral neuroscience, social, developmental, cognitive, behavioral pharmacology, etc.) are
encouraged to apply. Both human and animal research will be supported.

Applicants should submit a cover letter indicating areas of interest, CV, and three letters of
recommendation by January 10th. Please email AND mail materials to:

Tanya Eng‐Aquino, Division Administrator
Postdoctoral Psychology Training in Alcohol Research Program
Department of Psychiatry & Behavioral Sciences
University of Washington
1100 NE 45th Street, Suite 300
Box 354944
Seattle, WA 98195‐4944 tanyaeng@uw.edu

The UW is committed to training culturally diverse research fellows and strongly encourages
applications from female and minority candidates.

The University of Washington is an Equal Opportunity/Affirmative Action Employer. Due to the
Federal Guidelines only applicants who are national citizens or current green card holders will be
considered.

For a current list of Fellowship Faculty Members please visit our website at:
https://sharepoint.washington.edu/uwpsychiatry/Education/Research/Pages/Psychology‐Training‐in‐Alcohol‐ Research‐(PTAR)-Fellowship.aspx

For additional information, please contact:
Mary E. Larimer, PhD
Professor, Psychiatry and Behavioral Sciences
Director, Center for the Study of Health & Risk Behaviors Director, Addictive Behaviors Research
Center Department of Psychiatry & Behavioral Sciences University of Washington
1100 NE 45th Street, Suite 300
Seattle, WA 98195‐4944
Phone: 206‐543‐3513 // Fax: 206‐616‐1705
larimer@uw.edu

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] Faculty Position

This is posted on behalf of Dr. John V. Lavigne

Dustin

Chicago, IL – Faculty Clinical Psychologist, Adolescent and Young Adult Substance Use Disorders

Northwestern University Feinberg School of Medicine and the Ann & Robert H. Lurie Children's Hospital of Chicago are seeking a clinical psychologist to join a multidisciplinary Department of Child and Adolescent Psychiatry and Pediatric Division of Adolescent Medicine in a nationally-ranked, freestanding children's hospital located on the medical school campus. Duties are primarily to: 1) conduct screenings and outpatient diagnostic evaluations of adolescents and young adults who experience problems with substance use; 2) provide psychological treatment of and/or referrals for adolescents and young adults with substance use disorders and their families; 3) consult to parents, schools and medical/surgical staff; 4) teach in multidisciplinary child health, mental health, and adolescent medicine education and training programs; and 5) conduct research related to adolescent and young adult substance use disorders. Clinical and/or research experience with adolescents and young adults with problems with substance use is required. A PhD in clinical psychology and APA-approved internship are required, with at least one year of supervised experience with children and adolescents preferred. This position comes with 50% protected research time for the first 3 years of appointment. It is expected that the successful candidate will develop a program of research related to adolescent and young adult substance use disorders supported by external funding sources following the initial research support period.

Rank and salary commensurate with qualifications and experience. Full-time position. Start date immediate after licensure in Illinois. Anticipate spring/summer 2018 start, but earlier start date negotiable. Applications will be evaluated as received. Position is open until filled. To guarantee consideration, please send application materials by December 1, 2017. Please send CV with a letter describing clinical experience and clinical and academic interests and names of three professional references to: John Lavigne, PhD, Chief Psychologist, Lurie Children's Department of Psychiatry, 225 E. Chicago Ave. Box 10, Chicago IL, 60611-2605
Email: jlavigne@luriechildrens.org

Northwestern University and Lurie Children's Hospital are Equal Opportunity, Affirmative Action Employers of all protected classes, including veterans and individuals with disabilities. Women, underrepresented racial and ethnic minorities, individuals with disabilities, and veterans are encouraged to apply. Hiring is contingent upon eligibility to work in the United States and licensure in Illinois.

082317

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

2017-10-17

[#DIV28SUPER] FW: Call for Nominations - Division 28 Awards

Ok, let’s try that again!  Please don’t come to NYC in august!

We will be in San Francisco!!!

 

Dear Colleagues:  I am writing to encourage you to submit nomination materials for APA Division 28 Awards for the 2018 APA meeting in San Francisco.  Attached you will find the official call for nominations with the detailed instructions for each of the three awards:  Med Associates Brady-Schuster Award, Young Psychopharmacologist Award and Outstanding Dissertation Award.  These awards are an excellent way to recognize your outstanding colleagues in science- both the young and more seasoned!  The Awards Committee looks forward to seeing this year’s nominees.  The deadline for materials is January 15, 2018.  

 

Regards,

 

Cathy Stanger

 

 

Catherine Stanger, Ph.D.

Associate Professor

Department of Psychiatry

Geisel School of Medicine at Dartmouth

46 Centerra Parkway

Suite 300, HB 7255

Lebanon, NH 03766

Catherine.stanger@dartmouth.edu

Phone 603-646-7023

Fax 603-448-5335

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] FW: Call for Nominations - Division 28 Awards

Ok, let’s try that again!  Please don’t come to NYC in august!

We will be in San Francisco!!!

 

Dear Colleagues:  I am writing to encourage you to submit nomination materials for APA Division 28 Awards for the 2018 APA meeting in New York City.  Attached you will find the official call for nominations with the detailed instructions for each of the three awards:  Med Associates Brady-Schuster Award, Young Psychopharmacologist Award and Outstanding Dissertation Award.  These awards are an excellent way to recognize your outstanding colleagues in science- both the young and more seasoned!  The Awards Committee looks forward to seeing this year’s nominees.  The deadline for materials is January 15, 2018.  

 

Regards,

 

Cathy Stanger

 

 

Catherine Stanger, Ph.D.

Associate Professor

Department of Psychiatry

Geisel School of Medicine at Dartmouth

46 Centerra Parkway

Suite 300, HB 7255

Lebanon, NH 03766

Catherine.stanger@dartmouth.edu

Phone 603-646-7023

Fax 603-448-5335

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Postdoctoral Fellowship

T32 POSTDOCTORAL POSITIONS

Co-Occurring Substance Use and Mental Health Disorders

Geisel School of Medicine at Dartmouth

 

The Geisel School of Medicine at Dartmouth offers a unique postdoctoral training program in a developing area of transdisciplinary/translational research, co-occurring substance use and other mental disorders (COD) http://geiselmed.dartmouth.edu/scd/The philosophy of this program asserts that to effectively impact the problems of addiction and mental illness, one must be fully aware of their co-existence, etiologies, phenomenology, and clinical manifestations. Moreover, knowledge of integrated clinical approaches and the healthcare systems that serve those with co-occurring disorders are necessary to inform the questions to be asked in laboratory, animal and human imaging and clinical research studies.

 

At Dartmouth, six interconnected groups from neuroscience through implementation research, and across multiple departments provide research opportunities in intervention research, including digital health interventions, and developmental, social, behavioral, neurobiological mechanisms of addiction and co-occurring disorders. Faculty include preeminent national/international leaders and PhD and MD investigators with strong histories of training scientists. Program faculty lead diverse projects funded by many NIH institutes (NIDA, NIAAA, NIMH, NCI, NCATS and NICHD).

 

Appointment: Typically 2 years.  Eligibility: Applicants must have completed their training in psychology, or a related discipline and be U.S. citizens or permanent residents. Trainees are selected on the basis of scholastic record and commitment to a career in research related to addiction and mental health.  Benefits: Stipend, medical insurance coverage, and travel funds supported by NIH Institutional Training Awards.  For more information:  Contact Dr. Alan Budney (alan.budney@dartmouth.edu).  To apply: Forward curriculum vitae, statement of research interests, and 3 letters of reference to Brian Goodness, Operations Assistant (Brian.D.Goodness@dartmouth.edu). 

 

 

Alan Budney, Ph.D.

Geisel School of Medicine at Dartmouth

Department of Psychiatry

One Medical Center Drive, HB 7459

Lebanon, NH  03756

Email: alan.j.budney@dartmouth.edu

http://geiselmed.dartmouth.edu/scd/